Scott M Rawls Selected Research

Scott M Rawls Research Topics

Disease

16	Hypothermia 01/2011 - 06/2002
7	Substance-Related Disorders (Drug Abuse) 01/2022 - 04/2008
7	Pain (Aches) 01/2022 - 05/2005
7	Hyperthermia 09/2014 - 09/2003
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 08/2011
3	Inflammation (Inflammations) 03/2021 - 09/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 11/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2017
2	Neuroinflammatory Diseases 01/2017 - 01/2017
2	Central Nervous System Diseases (CNS Diseases) 03/2016 - 09/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2010 - 12/2006
1	Infections 03/2021
1	Spasm (Spasms) 01/2021
1	Memory Disorders (Memory Loss) 06/2020
1	Hyperalgesia 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Poisoning 03/2019
1	Brain Injuries (Brain Injury) 01/2017
1	Neutropenia 04/2015
1	Multiple Sclerosis 12/2012
1	Chronic Pain 12/2011
1	Tremor (Tremors) 03/2010
1	Opioid-Related Disorders (Opiate Addiction) 03/2010

Drug/Important Bio-Agent (IBA)

10	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 09/2003
9	Opioid Analgesics (Opioids)IBA 01/2022 - 05/2005
7	CannabinoidsIBA 01/2019 - 12/2005
5	Cocaine (Cocaine HCl)IBA 01/2022 - 03/2009
5	Chemokine ReceptorsIBA 01/2022 - 12/2018
4	ChemokinesIBA 01/2022 - 12/2018
4	Glutamic Acid (Glutamate)FDA Link 01/2022 - 09/2003
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 09/2014 - 10/2008
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2008 - 01/2006
4	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 08/2007 - 06/2002
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022 - 09/2014
3	Nicotine FDA Link 01/2022 - 12/2011
3	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 01/2020
3	Analgesics (Analgesic Drugs)IBA 11/2021 - 12/2018
3	Formaldehyde (Formol)FDA Link 11/2021 - 01/2019
3	Synthetic CathinoneIBA 03/2021 - 03/2019
3	Dopamine (Intropin)FDA LinkGeneric 06/2020 - 01/2020
3	Serotonin (5 Hydroxytryptamine)IBA 10/2010 - 05/2006
3	RimonabantIBA 09/2009 - 06/2002
3	Capsaicin (Zostrix)FDA Link 01/2008 - 12/2005
3	Cannabinoid Receptor AgonistsIBA 08/2007 - 12/2005
2	Pharmaceutical PreparationsIBA 11/2017 - 04/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2011 - 03/2010
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2011 - 05/2005
2	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2011 - 05/2006
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 09/2009 - 05/2009
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2008 - 05/2006
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2008 - 05/2006
2	LY 235959IBA 01/2008 - 09/2003
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2008 - 09/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2008 - 01/2006
2	AgmatineIBA 05/2007 - 12/2006
2	mu Opioid Receptors (mu Opioid Receptor)IBA 05/2007 - 09/2003
2	Drug CombinationsIBA 11/2006 - 01/2006
2	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 05/2006 - 04/2006
2	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 04/2006 - 12/2005
2	capsazepineIBA 04/2006 - 12/2005
2	Baclofen FDA LinkGeneric 01/2006 - 10/2004
1	D-Ala-peptide T-amideIBA 01/2022
1	RAP-103IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 01/2022
1	TRPA1 Cation ChannelIBA 01/2022
1	mephedroneIBA 03/2021
1	CytokinesIBA 01/2021
1	mitragynineIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	AlkaloidsIBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 06/2019
1	Meperidine (Pethidine)FDA LinkGeneric 06/2019
1	CarrageenanIBA 01/2019
1	plerixafor FDA Link 12/2018
1	Maraviroc FDA Link 12/2018
1	OrexinsIBA 11/2017
1	cathinoneIBA 11/2017
1	suvorexantIBA 11/2017
1	metabotropic glutamate receptor 2IBA 06/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 12/2012
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2012
1	Carbolines (Beta-Carbolines)IBA 09/2012
1	Harmine (Telepathine)IBA 09/2012
1	LactamsIBA 12/2011
1	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2010
1	beta-LactamsIBA 03/2010
1	Naloxone (Narcan)FDA LinkGeneric 03/2010

Therapy/Procedure

5	Analgesia 01/2022 - 12/2006
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2008
2	Therapeutics 09/2014 - 10/2010
2	Induced Hypothermia 08/2007 - 06/2002
1	Transcutaneous Electric Nerve Stimulation (TENS) 03/2019
1	Intravenous Administration 03/2016